Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bismuth Quadruple Therapy vs Standard Triple Therapy for H. pylori in Children
NCT06143124Phase 4Unknown
- Sponsor
- University Medical Centre Ljubljana
- Start
- Mar 2022
- Primary completion
- Nov 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of bismuth subcitrate in Helicobacter pylori infection, sponsored by University Medical Centre Ljubljana. Status: unknown.
02
Drugs
bismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06143124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06143124.